A noninvasive device that quickly and accurately assesses the elasticity of a patient’s small and large arteries, and thereby tests for early-stage endothelial dysfunction. Research indicates that cardiovascular disease (CVD) manifests in the small arteries and progresses into the large over time without proper diagnosis and treatment. The CVProfilor is the only FDA-approved, research-backed device, that quantitatively measures the elasticity of the small arteries in otherwise healthy individuals, by providing data not captured with simple blood pressure monitoring and stress tests. This in turn assists physicians with identifying where patients fall on the vascular disease continuum allowing the physician to accelerate correct treatment protocols to improve patient outcomes and overall vascular health. Fast, cost effective, reimbursable, and easy to use with test results printed in less than five minutes.